Cytokines and irritable bowel syndrome: where do we stand?

scientific article published on 16 December 2011

Cytokines and irritable bowel syndrome: where do we stand? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CYTO.2011.11.019
P698PubMed publication ID22178716

P50authorKeith A. SharkeyQ38328653
Nima RezaeiQ26464741
P2093author name stringMohammad Bashashati
Chun-Qiu Chen
Nasser Ebrahimi Daryani
Christopher N Andrews
Martin A Storr
P433issue2
P921main subjectirritable bowel syndromeQ838966
P304page(s)201-209
P577publication date2011-12-16
P1433published inCytokineQ15745296
P1476titleCytokines and irritable bowel syndrome: where do we stand?
P478volume57

Reverse relations

cites work (P2860)
Q35590592Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome
Q39311930Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis
Q28079482Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability
Q27011652Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis
Q38209378Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis
Q60043882Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study
Q35517355Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial
Q39166000Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome
Q88086374Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines
Q36001130Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
Q47095550Functional Bowel Disorders Are Associated with a Central Immune Activation
Q40642008Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome
Q55190074Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response.
Q38447499Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome.
Q36194938Irritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study
Q36207200Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications
Q35565145Irritable bowel syndrome: an integrated explanatory model for clinical practice
Q37629670Irritable bowel syndrome: emerging paradigm in pathophysiology
Q26765219Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
Q48156277Pain and somatic symptoms are sequelae of sexual assault: results of a prospective longitudinal study
Q34415870Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection
Q37099359Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas
Q52716489Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.
Q93186295The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
Q38905594The Traveling Microbiome
Q38032174The chronic gastrointestinal consequences associated with campylobacter
Q38588312Toward a better understanding of the central consequences of intestinal inflammation
Q51354980Update on military diarrhoea: current status and future plans.
Q36483008Virulence genes and cytokine profile in systemic murine Campylobacter coli infection

Search more.